The Weekly Litigation News Digest is now live. Subscribe now

Methods For Reducing Lipoprotein(A) Levels By Administering An Inhibitor Of Proprotein Convertase Subtilisin Kexin-9 (Pcsk9) - EP3536712

The patent EP3536712 was granted to Regeneron Pharmaceuticals on May 31, 2023. The application was originally filed on Sep 12, 2012 under application number EP19162319A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3536712

REGENERON PHARMACEUTICALS
Application Number
EP19162319A
Filing Date
Sep 12, 2012
Status
Granted And Under Opposition
Apr 28, 2023
Publication Date
May 31, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

AMGENFeb 29, 2024BIJVANKADMISSIBLE
AMGENFeb 29, 2024DORRIESADMISSIBLE
AMGENFeb 29, 2024DORRIES, HANS ULRICH , DF-MP DORRIES FRANK-MOLNIA & POHLMANADMISSIBLE

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2010166768
DESCRIPTIONUS6596541
OPPOSITIONUS2010166768
OPPOSITIONWO2009026558
OPPOSITIONWO2010077854
OPPOSITIONWO2013016648
OPPOSITIONWO2015054619
OTHEREP2756004
OTHERWO2011028938
SEARCHWO2011028938

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents